• 1
    Brewster DR, Kwiatkowski D, White N. Neurological sequelae of cerebral malaria in children. Lancet 1990; ii: 103943.
  • 2
    Grau GE, Fajardo LF, Piguet PF, Allet B, Lambert PH, Vassali P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 1987; 237: 12102.
  • 3
    Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassali P, Homel M, Lambert P. Tumor necrosis factor and disease severity in children with P. falciparum malaria. N Engl J Med 1989; 320: 158691.
  • 4
    Kwiatkowski D, Hill I, Sambou I et al. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 1990; ii: 12014.
  • 5
    Kern P, Hemmer C, van Damme J, Gruss HJ, Dietrich M. Elevated tumor necrosis factor alpha and interleukin-6 plasma levels as markers for complicated Plasmodium falciparum malaria. Am J Med 1989; 87: 13943.
  • 6
    De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE. Interleukin 10 (IL 10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL 10 produced by monocytes. J Exp Med 1989; 17: 120920.
  • 7
    Chomarat P, Rissoan M, Banchereau J, Miossec P. Interferon inhibits interleukin-10 production by monocytes. J Exp Med 1993; 177: 5237.
  • 8
    Yssel HR, De Waal Malefyt R, Roncarolo MG, Abrams JS, Lahesmaa R, Spits H, De Vries JE. IL 10 produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol 1992; 149: 237884.
  • 9
    Burdin N, Péronne C, Banchereau J, Rousset F. Epstein–Barr virus-transformation induces B lymphocytes to produce human interleukin-10. J Exp Med 1993; 177: 295304.
  • 10
    De Waal Malefyt R, Haanen J, Spits H et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991; 174: 91524.
  • 11
    Defrance T, Vanbervliet B, Brière F, Durand I, Rousset F, Banchereau J. Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med 1992; 175: 67182.
  • 12
    Rousset F, Garcia E, Defrance T et al. Interleukin 10 is a potent growth and differentiation factor for activated human B Lymphocytes. Proc Natl Acad Sci USA 1992; 89: 18903.
  • 13
    Grazzinelli RT, Oswald IP, James SL, Sher A. IL 10 inhibits parasites killing and nitrogen oxide production by IFNγ activated macrophages. J Immunol 1992; 148: 7926.
  • 14
    Silva JS, Morrissey PJ, Grabstein KH, Mohler KM, Anderson D, Reed SG. Interleukin 10 and interferon γ regulation of experimental Trypanosoma cruzi infection. J Exp Med 1992; 175: 16974.
  • 15
    Heinzel FP, Sadick MD, Mutha SS, Locksley RM. Production of interferon γ, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci USA 1991; 88: 70115.
  • 16
    Sher A, Fiorentino D, Caspar P, Pearce E, Mosmann T. Production of IL 10 by CD4+ T lymphocytes correlates with down-regulation of Thl cytokine synthesis in helminth infection. J Immunol 1991; 147: 27136.
  • 17
    Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991; 174: 154955.
  • 18
    WarrellDA, MolyneuxME, BealesPF, eds. Severe and complicated malaria, 2nd edn. Trans Roy Trop Med Hyg 1990; 84, Suppl.2.
  • 19
    Abrams JS, Roncarolo M, Yssel H, Andersson U, Gleich GJ, Silver JE. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 1992; 27: 524.
  • 20
    Greenwood BM, Muller AS, Valkenburg HA. Rheumatoid factor in Nigerian sera. Clin Exp Immunol 1971; 8: 16173.
  • 21
    Blay JY, Burdin N, Rousset F et al. Plasma IL-10 levels as prognostic factor in patients with non Hodgkin's lymphoma. Blood, 1993; 82: 216974.
  • 22
    Merville P, Rousset F, Banchereau J, Klein B, Bataille R. Elevated interleukin-10 (IL-10) in the plasma of patients with early stage multiple myeloma. Lancet 1992; 340: 15445.
  • 23
    Harpaz R, Edelman R, Wasserman SS, Levine MM, Davis JR. Plasma cytokine profiles in experimental human malaria. J Clin Invest 1992; 90: 51523.